Antigenic analysis of Rhodococcus equi preparations using different horse sera.

This research analyzes an R. equi vaccine, meant to protect horses from bacterial pneumonia, comparing it with other R. equi preparations and studying how it interacts with various horse sera. Particularly, the study focuses on the presence and role of antigens within the vaccine, questioning the sole dominance of VapA in inducing protective antibodies, hypothesizing that higher molecular weight antigens may also play a crucial role.

Research Context and Methodology

• The research focused on the analysis of a vaccine for Rhodococcus equi, a bacterium that can cause severe pneumonia in foals (young horses).
• The vaccine in question was prepared under specific conditions to express numerous antigens and has shown promising results in field trials.
• The researchers used SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) and immunoblots to inspect the vaccine and compare it with other R. equi preparations.
• The other preparations include a likewise prepared solution from a less virulent bacteria strain (VapA-negative), a whole cell preparation of a VapA-positive R. equi, and a semipurified VapA preparation (APTX).
• The antigens in these preparations were then examined using various horse sera, including sera from passively and actively immunized foals, and from horses vaccinated with the R. equi vaccine.

Key Observations and Findings

• The study’s vaccine exhibited a high concentration of proteins, with hyperimmune sera reacting strongly with vaccine antigens, specifically in high molecular weight areas.
• Passively immunized foals’ sera showed a somewhat similar but less potent reaction. Active immunization, however, resulted in very weak reactions.
• The Mab reacted to bands at 15-17, 44, and 66 kDa in the APTX extract. However, reactivity was considerably lower with the whole cell and non-existent with VapA-negative preparations.
• The vaccine did not establish the expected reaction in the 15-17 kDa region with the APTX antiserum and the Mab, suggesting a modification of VapA’s native form, albeit without loss of its antigenicity.

Conclusions and Implications

• The research proposes that higher molecular weight antigens, besides VapA, might be vital in generating antibodies that safeguard foals from R. equi pneumonia.
• This aligns with the high concentrations of these antigens in the vaccine and their immunogenic form.
• The findings may represent a shift in how R. equi vaccines are formulated and understood, highlighting the role of antigens beyond VapA.